Martin Short has spent 50 years in the spotlight, but "game show host" was never among his many accolades until now, when he serves as ringleader tonight, July 23, for ABC's "Match Game" revival.

A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...

Gerald Gene Fenno, age 69, of Columbus, PA, started his new journey on Tuesday, September 23, 2025, surrounded by his family. He was born in Corry on December 28, 1955, son of the late Charles and ...

It’s the year of Britpop revival. In last night’s case, Gene reunited at Brudenell Social Club in Leeds to play a two-hour set. Gene — singer Martin Rossiter, guitarist Steve Mason, bassist Kevin ...

The first participant in an investigational gene therapy trial of STXBP1 encephalopathy died, Capsida Biotherapeutics said. The death occurred days after dosing, according to information posted on the ...

PROVIDENCE, R.I. (WJAR) — It's the end of an era in Providence on Saturday. Olneyville New York System will officially change hands to a new owner. For the past 80 years, its been operated by the ...

AUSTIN (KXAN) — An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia ...

Biogen has discontinued all gene therapy programs using adeno-associated virus (AAV) capsids, instead shifting resources to modalities that have the highest likelihood of achieving better treatment ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...